Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
US7943635B2 · kind B2 · utility
7Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2007 |
| Grant date | May 17, 2011 |
| Priority date | — |
| Expiry date | Mar 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention comprises the novel compounds of formula (I)wherein r, t, Y1, Y2, R1, R2, R3, R5, R6 and R7 have defined meanings, having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.